Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196


Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF.

Sanford JR, Coutinho P, Hackett JA, Wang X, Ranahan W, Caceres JF.

PLoS One. 2008 Oct 8;3(10):e3369. doi: 10.1371/journal.pone.0003369.


Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor.

Sanford JR, Ellis JD, Cazalla D, Cáceres JF.

Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15042-7. Epub 2005 Oct 6.


A novel role for shuttling SR proteins in mRNA translation.

Sanford JR, Gray NK, Beckmann K, Cáceres JF.

Genes Dev. 2004 Apr 1;18(7):755-68.


Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.

Blanco FJ, Bernabeu C.

Aging Cell. 2011 Oct;10(5):896-907. doi: 10.1111/j.1474-9726.2011.00727.x. Epub 2011 Jul 19.


Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.

Lemaire R, Prasad J, Kashima T, Gustafson J, Manley JL, Lafyatis R.

Genes Dev. 2002 Mar 1;16(5):594-607.


SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms.

Blaustein M, Quadrana L, Risso G, Mata Mde L, Pelisch F, Srebrow A.

J Cell Biochem. 2009 Jul 1;107(4):826-33. doi: 10.1002/jcb.22181.


The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1.

Michlewski G, Sanford JR, Cáceres JF.

Mol Cell. 2008 Apr 25;30(2):179-89. doi: 10.1016/j.molcel.2008.03.013.


SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control.

Sun S, Zhang Z, Sinha R, Karni R, Krainer AR.

Nat Struct Mol Biol. 2010 Mar;17(3):306-12. doi: 10.1038/nsmb.1750. Epub 2010 Feb 7.


Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.

Ropers D, Ayadi L, Gattoni R, Jacquenet S, Damier L, Branlant C, Stévenin J.

J Biol Chem. 2004 Jul 16;279(29):29963-73. Epub 2004 Apr 27.


Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF.

Sinha R, Allemand E, Zhang Z, Karni R, Myers MP, Krainer AR.

Mol Cell Biol. 2010 Jun;30(11):2762-74. doi: 10.1128/MCB.01270-09. Epub 2010 Mar 22.


The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Petersen-Mahrt SK, Estmer C, Ohrmalm C, Matthews DA, Russell WC, Akusjärvi G.

EMBO J. 1999 Feb 15;18(4):1014-24.


The splicing factor ASF/SF2 is associated with TIA-1-related/TIA-1-containing ribonucleoproteic complexes and contributes to post-transcriptional repression of gene expression.

Delestienne N, Wauquier C, Soin R, Dierick JF, Gueydan C, Kruys V.

FEBS J. 2010 Jun;277(11):2496-514. doi: 10.1111/j.1742-4658.2010.07664.x. Epub 2010 Apr 30.


HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.

Powell DM, Amaral MC, Wu JY, Maniatis T, Greene WC.

Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):973-8.


Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Mayeda A, Helfman DM, Krainer AR.

Mol Cell Biol. 1993 May;13(5):2993-3001. Erratum in: Mol Cell Biol 1993 Jul;13(7):4458.


High-throughput binding analysis determines the binding specificity of ASF/SF2 on alternatively spliced human pre-mRNAs.

Chang B, Levin J, Thompson WA, Fairbrother WG.

Comb Chem High Throughput Screen. 2010 Mar;13(3):242-52.

Supplemental Content

Support Center